Author

Natalie S. Nahirney

University of British Columbia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Abby G Gordon· 1 shared Andrew G. EdwardsiD· 1 shared Chieh Min Jamie ChuiD· 1 shared Evgeniy PanzhinskiyiD· 1 shared Haoning Howard CeniD· 1 shared James D. JohnsoniD· 1 shared Jelena KoliciD· 1 shared Jiashuo Aaron ZhangiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Abby G Gordon

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PhysiologybioRxivPreprintJun 11, 2023

Pharmacological or genetic inhibition of Scn9a protects human and mouse beta cells while dampening insulin secretion in type 1 diabetes

Peter Overby, Abby G Gordon, Xiao-Qing Dai…·James D. Johnson

This study shows that inhibiting Scn9a protects beta cells in type 1 diabetes by reducing excitability and improving survival, while also dampening insulin secretion.

2 citations

humanmouse

𝕏 PostBluesky